Erosive Esophagitis Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Erosive Esophagitis Epidemiology Forecast Report Coverage

Expert Market Research's “Erosive Esophagitis Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of erosive esophagitis. It projects the future incidence and prevalence rates of erosive esophagitis cases across various populations. The study covers age and type as major determinants of the erosive esophagitis population. The report highlights patterns in the prevalence of erosive esophagitis over time and projects future trends based on multiple variables.

Erosive Esophagitis Understanding: Disease Overview

Erosive esophagitis is a condition where the lining of the esophagus becomes inflamed and damaged. This can happen due to the frequent backflow of stomach acid, commonly linked to gastroesophageal reflux disease (GERD). This acid reflux leads to the erosion or ulceration of the esophageal lining. Erosive esophagitis results in visible damage to the esophagus and is considered a more severe form of esophagitis compared to non-erosive esophagitis.

Common symptoms of erosive esophagitis include heartburn, chest pain, difficulty swallowing (dysphagia), and regurgitation of food or acid, among others. In more severe cases, erosive esophagitis patients may experience bleeding or the formation of scar tissue.

Erosive Esophagitis Epidemiology Perspective

The erosive esophagitis epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for erosive esophagitis epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for the disease and their trends. The erosive esophagitis detailed epidemiology segmentation is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• Experts estimate that reflux or erosive esophagitis affects 1% of the population, with gastroesophageal reflux considered one of the most common causes.
• Population-based studies have shown that the prevalence of erosive esophagitis varies between 6.4% and 15.5%, regardless of the presence of GERD symptoms. In individuals without GERD symptoms, the erosive esophagitis prevalence ranged from 6.1% to 9.5%.
• As per Savarino, E. et al. (2017), erosive esophagitis is reported in roughly 30% of GERD cases. Additionally, in 1% to 13% of cases, erosive esophagitis may evolve to Barrett's esophagus.
• In a prospective, multicenter cohort study conducted in Japan (2018), 47% of patients with erosive esophagitis (EE) were reported to be asymptomatic, while 37% experienced mild symptoms.
• Erosive esophagitis is estimated to be more prevalent in males (11%) compared to females, as per Kim et al.

Read more about this report - Request a Free Sample

Country-wise Erosive Esophagitis Epidemiology Segment

The erosive esophagitis epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of erosive esophagitis varies significantly between countries due to differences in factors such as dietary habits, prevalence of gastroesophageal reflux disease (GERD), access to healthcare, lifestyle factors (including smoking, alcohol consumption, and obesity), and genetic predispositions, among others. In India, less than 10% of gastroesophageal reflux disease patients suffer from erosive esophagitis, as per a research article published in the Indian Journal of Gastroenterology (2019).

Erosive Esophagitis: Treatment Overview

Proton pump inhibitors (PPIs), such as omeprazole and esomeprazole, are the primary treatment for erosive esophagitis. These drugs work by decreasing stomach acid production, allowing the esophagus to heal. H2-receptor antagonists like ranitidine or famotidine are also prescribed to the patients. However, they are reported to be less effective than proton pump inhibitors.

Other erosive esophagitis therapeutics include antacids and alginates, which offer short-term relief from symptoms. Along with medication, lifestyle and dietary changes are recommended for effective management of erosive esophagitis.

Key Questions Answered

• What are the key findings of erosive esophagitis epidemiology in the 8 major markets?
• What will be the total number of patients with erosive esophagitis across the 8 major markets during the forecast period?
• What was the country-wise erosive esophagitis epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of erosive esophagitis patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of erosive esophagitis during the forecast period of 2026-2035?
• What are the currently available treatments in the erosive esophagitis market?
• What are the disease risks, signs, symptoms, and unmet needs of erosive esophagitis?

Scope of the Erosive Esophagitis Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of erosive esophagitis based on several factors.
• The Erosive Esophagitis Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The erosive esophagitis report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Gastroenterology Market Report

Esophageal Cancer Market Report